Although a BETi (JQ1) is proved to attenuate CD4+FOXP3+ Treg cell suppressive function in lung cancer therapy [123], how BET family proteins associate with FOXP3-promoting Treg cell functions is still unknown. This evidence concerns the gene FOXP3 and lung cancer.